Combination of Olmesartan and calcium channel blocker or low dose diuretics in high risk elderly hypertensive patients study (COLM-study)

Trial Profile

Combination of Olmesartan and calcium channel blocker or low dose diuretics in high risk elderly hypertensive patients study (COLM-study)

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Oct 2015

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Amlodipine; Azelnidipine; Indapamide; Thiazide diuretics; Trichlormethiazide
  • Indications Cardiovascular disorders; Essential hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms COLM
  • Most Recent Events

    • 17 Jun 2013 Tolerability results presented at the 23rd European Meeting on Hypertension.
    • 17 Jun 2013 Primary analysis presented at the 23rd European Meeting on Hypertension.
    • 01 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top